We are live on
!
Find out more
HP
Hikari Power Portfolio holdings
AUM
$855M
Turnover
22.64%
1-Year Est. Return
14.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.3%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$741M
AUM Growth
+$38.7M
(+5.5%)
Cap. Flow
+$31.5M
Cap. Flow
% of AUM
4.25%
Top 10 Holdings %
Top 10 Hldgs %
60.64%
Holding
104
New
35
Increased
22
Reduced
3
Closed
10
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wabtec
WAB
|
+$12.3M |
| 2 |
Waters Corp
WAT
|
+$9M |
| 3 |
Diamond Offshore Drilling
DO
|
+$6.09M |
| 4 |
Gilead Sciences
GILD
|
+$5.17M |
| 5 |
RTX Corp
RTX
|
+$4.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$27.9M |
| 2 |
Cisco
CSCO
|
+$2.32M |
| 3 |
Ligand Pharmaceuticals
LGND
|
+$1.06M |
| 4 |
United Therapeutics
UTHR
|
+$1.05M |
| 5 |
DBV Technologies S.A. American Depositary Shares
DBVT
|
+$1.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.94% |
| 2 | Healthcare | 24.83% |
| 3 | Industrials | 11.96% |
| 4 | Technology | 10.74% |
| 5 | Energy | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
DELISTED
CSG Systems International
CSGS
| $217K | 0.03% |
+5,350
| New | +$210K |
2017 Q2
0 quarters
|
|
77
NVR
NVR
$15.8B
| $217K | 0.03% |
+90
| New | +$203K |
2017 Q2
0 quarters
|
|
78
Cigna
CI
$79B
| $216K | 0.03% |
+1,290
| New | +$207K |
2017 Q2
0 quarters
|
|
79
Steven Madden
SHOO
$3.38B
| $211K | 0.03% |
+7,935
| New | +$202K |
2017 Q2
0 quarters
|
|
80
DELISTED
CA, Inc.
CA
| $211K | 0.03% |
+6,130
| New | +$198K |
2017 Q2
0 quarters
|
|
81
NetEase
NTES
$81.4B
| $210K | 0.03% |
+3,500
| New | +$201K |
2017 Q2
0 quarters
|
|
82
Smith & Wesson
SWBI
$635M
| $210K | 0.03% |
+12,333
| New | +$213K |
2017 Q2
0 quarters
|
|
83
Wabash National
WNC
$522M
| $209K | 0.03% |
+9,510
| New | +$201K |
2017 Q2
0 quarters
|
|
|
RTN
84
DELISTED
Raytheon Company
RTN
| $208K | 0.03% |
+1,290
| New | +$204K |
2017 Q2
0 quarters
|
|
85
VeriSign
VRSN
$27.5B
| $207K | 0.03% |
+2,230
| New | +$201K |
2017 Q2
0 quarters
|
|
86
Ubiquiti
UI
$37.4B
| $205K | 0.03% |
+3,950
| New | +$195K |
2017 Q2
0 quarters
|
|
87
Robert Half
RHI
$3.52B
| $204K | 0.03% |
+4,260
| New | +$199K |
2017 Q2
0 quarters
|
|
88
Silicon Motion
SIMO
$7.41B
| $204K | 0.03% |
+4,230
| New | +$209K |
2017 Q2
0 quarters
|
|
89
Baidu
BIDU
$28.1B
| $200K | 0.03% |
+1,120
| New | +$203K |
2017 Q2
0 quarters
|
|
|
RAI
90
DELISTED
Reynolds American Inc
RAI
| $200K | 0.03% |
+3,080
| New | +$201K |
2017 Q2
0 quarters
|
|
91
Tuniu
TOUR
$53.9M
| $189K | 0.03% |
+2,352
| New | +$193K |
2017 Q2
0 quarters
|
|
92
Vipshop
VIPS
$6.26B
| $152K | 0.02% |
+14,450
| New | +$189K |
2017 Q2
0 quarters
|
|
93
Abeona Therapeutics
ABEO
$266M
| – | – |
-1,200
| Closed | -$150K | – |
|
94
Aurinia Pharmaceuticals
AUPH
$2.23B
| – | – |
-60,000
| Closed | -$440K | – |
|
95
Celldex Therapeutics
CLDX
$2.27B
| – | – |
-3,333
| Closed | -$181K | – |
|
|
96
DBV Technologies S.A. American Depositary Shares
DBVT
$573M
| – | – |
-2,912
| Closed | -$1.03M | – |
|
97
Lineage Cell Therapeutics
LCTX
$250M
| – | – |
-40,318
| Closed | -$122K | – |
|
|
98
Ligand Pharmaceuticals
LGND
$5.95B
| – | – |
-16,030
| Closed | -$1.06M | – |
|
99
ProQR Therapeutics
PRQR
$205M
| – | – |
-24,144
| Closed | -$121K | – |
|
100
Cartesian Therapeutics
RNAC
$199M
| – | – |
-812
| Closed | -$349K | – |
|
Similar funds
TPW
EWA
DCM
BC
QIM
AIMC
F
AAM
Hikari Power's Q2 2017 Portfolio in Review
As of Q2 2017, Hikari Power held 104 positions worth $741M, up 5.5% from $703M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Hikari Power deployed $31.5M of net new capital in Q2 2017, opening 35 new positions and adding to 22 existing holdings. Its largest new stake was Waters Corp: 51,800 shares worth $9.52M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was IBM, an estimated $27.9M trimmed.
- Hikari Power's largest Q2 2017 buy was Waters Corp: 51,800 shares worth $9.52M.
- Hikari Power added most to Wabtec in Q2 2017, an estimated $12.3M increase.
- Hikari Power's biggest Q2 2017 reduction was IBM, cutting an estimated $27.9M.
- Hikari Power fully exited Ligand Pharmaceuticals in Q2 2017, selling an estimated $1.06M.
- Hikari Power's ten largest holdings make up 61% of its $741M portfolio in Q2 2017.
- Hikari Power opened 35 new positions and closed 10 in Q2 2017.
- Hikari Power's portfolio value rose 5.5% quarter-over-quarter to $741M.
Based on Hikari Power's 13F filing for Q2 2017, filed 9 Aug 2017.